European Medicines Agency: * EMA: EMA’S EMERGENCY TASK FORCE ADVISES ON INTRADERMAL USE OF IMVANEX / JYNNEOS AGAINST MONKEYPOX : 19/08/2022
* EMA: ETF CAUTIONED HIGHER RISK OF LOCAL REACTIONS (E.G. LONGER-LASTING REDNESS, THICKENING OR DISCOLORATION OF SKIN) AFTER INTRADERMAL INJECTIONS * EMA: NATIONAL AUTHORITIES MAY DECIDE TO USE IMVANEX TEMPORARILY AS INTRADERMAL INJECTION AT LOWER DOSE TO PROTECT AT-RISK INDIVIDUALS
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
CalFresh recipients must complete recertification by the deadline in August 2025 to keep receiving food…
Changes in Medicare 2026: A big change is on the way that will affect millions of…
Millions on Social Security will see slightly higher checks in August 2025, thanks to the…
Veterans receiving VA disability payments will see a 2.5% increase in August 2025. This boost,…
Thousands of low-income families in Florida are waiting for August’s Temporary Cash Assistance, expected within…
Florida SNAP benefits for August 2025 will be paid between the 1st and 28th, based…